Faculty, Staff and Student Publications
Publication Date
9-11-2023
Journal
Scientific Reports
Abstract
In this work, we investigated the oncogenic role of Streptococcus gallolyticus subsp. gallolyticus (SGG), a gut bacterium associated with colorectal cancer (CRC). We showed that SGG UCN34 accelerates colon tumor development in a chemically induced CRC murine model. Full proteome and phosphoproteome analysis of murine colons chronically colonized by SGG UCN34 revealed that 164 proteins and 725 phosphorylation sites were differentially regulated. Ingenuity Pathway Analysis (IPA) indicates a pro-tumoral shift specifically induced by SGG UCN34, as ~ 90% of proteins and phosphoproteins identified were associated with digestive cancer. Comprehensive analysis of the altered phosphoproteins using ROMA software revealed up-regulation of several cancer hallmark pathways such as MAPK, mTOR and integrin/ILK/actin, affecting epithelial and stromal colonic cells. Importantly, an independent analysis of protein arrays of human colon tumors colonized with SGG showed up-regulation of PI3K/Akt/mTOR and MAPK pathways, providing clinical relevance to our findings. To test SGG's capacity to induce pre-cancerous transformation of the murine colonic epithelium, we grew ex vivo organoids which revealed unusual structures with compact morphology. Taken together, our results demonstrate the oncogenic role of SGG UCN34 in a murine model of CRC associated with activation of multiple cancer-related signaling pathways.
Keywords
Humans, Animals, Mice, Disease Models, Animal, Phosphatidylinositol 3-Kinases, Proteomics, TOR Serine-Threonine Kinases, Colonic Neoplasms, Phosphoproteins, Proteome, Streptococcus gallolyticus subspecies gallolyticus, Signal Transduction, Cancer, Microbiology
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Microbiology Commons, Oncology Commons
Comments
This article has been corrected. See Sci Rep. 2023 Oct 17;13:17676.
Associated Data
PMID: 37696912